Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals Market Cap: 3.763B for Dec. 9, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| AbbVie, Inc. | 394.11B |
| Johnson & Johnson | 481.76B |
| Amgen, Inc. | 169.00B |
| United Therapeutics Corp. | 20.51B |
| Xeris Biopharma Holdings, Inc. | 1.163B |
Market Cap Related Metrics
| PE Ratio | 848.94 |
| PS Ratio | 1.306 |
| Price to Free Cash Flow | 16.21 |
| Price | 11.97 |
| Earnings Yield | 0.12% |
| Operating PE Ratio | 10.52 |
| Normalized PE Ratio | 111.35 |